Laura M. Periman, MD

Artificial intelligence has the potential to improve ophthalmology practices by streamlining documentation, enhancing screening capabilities, and guiding more effective treatment decisions.

Peter J. McDonnell, MD, and Laura M. Periman, MD, discuss recent innovations in ophthalmology, emphasizing ocular surface disease and the growing complexity of care at EyeCon 2024, held September 27 and 28, in Fort Lauderdale, Florida.

Laura M. Periman, MD, shares her passion for dry eye disease, discussing her discovery of the Alpenglow Sign in Demodex blepharitis and her insights on research and education for clinicians. Periman will join the EyeCon 2024 faculty as Honorary Chair.

Dry eye experts discuss the future of dry eye management.

Dry eye experts discuss Cyclosporine ophthalmic solution.

Dry eye experts discuss how they use a comprehensive dry eye diagnostic approach to tailor and customize individual patients.

Dry eye experts discuss how they tailor dry eye treatment based on diagnostic test results and other factors.

Dry eye experts discuss how they use a comprehensive dry eye diagnostic approach to tailor and customize individual patients.

Dry eye experts discuss how they use a comprehensive dry eye diagnostic approach to tailor and customize individual patients.

Dry eye experts discuss tear film assessment techniques and emphasize the importance of distinguishing between aqueous-deficient and evaporative dry eye for targeted treatment approaches.

New options open possibilities for treatment, resulting in better outcomes for patients.

Poor eyelid performance while sleeping a common contributing factor

Many medical specialties share medications and technologies, from various classes of drugs to diagnostic testing and surgical instruments. Here are just a few “adopted” technologies we’re happy to see in the hands of ophthalmologists.

Start ocular surface treatment 6 weeks prior to cataract surgery for best outcomes